InMode Ltd. logo

InMode Ltd. (INMD)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
15. 47
-0.12
-0.8015%
$
857.61M Market Cap
10.42 P/E Ratio
- Div Yield
609,900 Volume
2.51 Eps
$ 15.6
Previous Close
Add Transaction
Day Range
15.39 15.67
Year Range
12.72 16.74
Want to track INMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

INMD closed today lower at $15.47, a decrease of -0.8015% from yesterday's close, completing a monthly increase of 12.1014% or $1.67. Over the past 12 months, INMD stock gained 4.9525%.
INMD is not paying dividends to its shareholders.
The last earnings report, released on May 04, 2026, missed the consensus estimates by -0.3369%. On average, the company has fell short of earnings expectations by -0.2423%, based on the last three reports.
InMode Ltd. has completed 3 stock splits, with the recent split occurring on Oct 01, 2021.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

INMD Chart

People also search for

Tyra Biosciences, Inc.
$ 32.13
+1.645%
Stoke Therapeutics Inc.
$ 29.05
-0.2061%
MBX
MBX Biosciences, Inc.
$ 62.92
+7.8875%
Sarepta Therapeutics Inc.
$ 17.22
-0.058%
BLU
BELLUS Health Inc
$ 14.74
+0.0339%
InMode: My Pick For A Major Turnaround In 2026 And 2027

InMode: My Pick For A Major Turnaround In 2026 And 2027

InMode Ltd. remains a global leader in minimally-invasive aesthetics, with proprietary RF and laser technologies and a strong international growth trajectory. I maintain a Strong Buy rating for INMD, citing undervaluation, robust free cash flow, a fortress balance sheet, and aggressive share repurchases. U.S. market saturation and sales execution remain challenges, but leadership changes and new product launches are driving positive cultural and operational shifts.

Seekingalpha | 1 month ago
InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript

InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript

InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
InMode (NASDAQ:INMD) Shares Gap Up   – What’s Next?

InMode (NASDAQ:INMD) Shares Gap Up – What’s Next?

InMode Ltd. (NASDAQ: INMD - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $12.76, but opened at $13.71. InMode shares last traded at $13.5850, with a volume of 653,419 shares changing hands. Wall Street Analysts Forecast Growth A number of research firms have recently weighed in on

Defenseworld | 4 months ago

InMode Ltd. Investors

Name Quantity Cost Value Profit ($) Gain (%)
CE
Curtis Ellergodt Rothschild Investment LLC
3,640 $54,236.32 $55,514 $1,277.68 2.36%
YA
Yinka Akinsola Blue Trust Inc.
5,567 $84,565.07 $84,749.22 $184.15 0.22%
JB
James Bennett Marathon Asset Management Ltd.
154,688 $3.42M $2.36M -$1.06M -31.09%
Joseph Castro
Joseph Castro Nuveen LLC
42,752 $758,420.42 $652,181.76 -$106,238.66 -14.01%
LEL
Libby E. Liebig Villanova Investment Management Co. LLC
74,093 $1.08M $1.13M $44,290.2 4.09%

InMode Ltd. Analysts

Name Quantity Cost Value Profit ($) Gain (%)
Kyle Rose
Kyle Rose Canaccord Genuity
1,416.36 $27,888.23 $21,804.94 -$6,083.29 -21.81%

InMode Ltd. (INMD) FAQ

What is the stock price today?

The current price is $15.47.

On which exchange is it traded?

InMode Ltd. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is INMD.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 857.61M.

Has InMode Ltd. ever had a stock split?

InMode Ltd. had 3 splits and the recent split was on Oct 01, 2021.

InMode Ltd. Profile

Health Care Technology Industry
Healthcare Sector
Moshe Mizrahy CEO
NASDAQ (NGS) Exchange
M5425M103 CUSIP
IL Country
660 Employees
- Last Dividend
1 Oct 2021 Last Split
8 Aug 2019 IPO Date

Overview

InMode Ltd. is a pioneering company known for its design, development, manufacturing, and international marketing of innovatively minimally invasive aesthetic medical products. Leveraging proprietary technologies like radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency, InMode aims to offer advanced solutions for a variety of aesthetic medical procedures. Originating as Invasix Ltd., the company undertook a rebranding initiative, adopting the name InMode Ltd. in November 2017. Since its incorporation in 2008, with headquarters based in Yokneam, Israel, InMode has dedicated itself to improving patient outcomes and experiences in the aesthetic medicine field through its diverse product range, serving both the domestic market in the United States and global clients.

Products and Services

InMode's product portfolio is distinguished by a wide array of minimally invasive and non-invasive medical aesthetic solutions targeting an extensive range of procedures and conditions:

  • Liposuction with Simultaneous Skin Tightening: By employing advanced radiofrequency technology, InMode's products enable efficient fat removal while simultaneously tightening the skin. This technique offers a dual benefit during the liposuction process, enhancing body contours and improving skin laxity.
  • Body and Face Contouring: The company's devices are designed for comprehensive contouring solutions. These systems help in sculpting and defining the body and facial features, providing aesthetically pleasing results with minimal downtime.
  • Ablative Skin Rejuvenation Treatments: InMode's technology facilitates ablative treatments that effectively rejuvenate the skin by addressing concerns such as fine lines, wrinkles, and skin texture. Through precision targeting, the skin is stimulated to renew itself, leading to a fresher, more youthful appearance.
  • Women's Health Conditions and Procedures: Recognizing the unique aesthetic and health needs of women, InMode offers specialized products that contribute to women's wellness and beauty, addressing conditions that affect a woman's body over different life stages.
  • Permanent Hair Reduction: Through non-invasive techniques, InMode provides solutions for long-lasting hair reduction. These products cater to various body areas, offering an effective alternative to traditional hair removal methods.
  • Facial Skin Rejuvenation: Emphasizing facial aesthetics, InMode's offerings foster skin rejuvenation. These treatments target the reduction of wrinkles, improvement in skin texture, and overall complexion enhancement, promoting a revitalized facial look.
  • Cellulite Treatment: Addressing the common concern of cellulite, InMode's solutions are crafted to reduce the appearance of cellulite, leading to smoother, firmer skin through non-invasive treatments.
  • Skin Appearance and Texture Improvement: Focusing on the enhancement of skin appearance and texture, InMode's products provide options for individuals seeking to refine their skin's overall quality and feel.
  • Treatment of Superficial Benign Vascular and Pigmented Lesions: The company's technology also extends to the treatment of benign vascular and pigmented lesions, offering non-invasive options to reduce and eliminate these common skin concerns.
  • Hands-Free Medical Aesthetic Procedures: Expanding its range to include hands-free solutions, InMode allows for treatments such as skin tightening, fat reduction, and muscle stimulation without the need for direct operator control, facilitating a more versatile approach to aesthetic care.

Contact Information

Address: Tavor Building
Phone: 972 4 909 6313